ARS-853 from MedChemExpress

ARS-853 is a cell-active, selective, covalent KRAS G12C inhibitor with an IC50 of 2.5 µM. ARS-853 inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation[1][2]